Scholars Central

Conference abstractPublished 21 Oct 2013

Herb - Modern drug interactions

Authors: Ciddi Veeresham

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A clear surge in the usage of herbal drugs for preventive and therapeutic purposes is been witnessed for the reason of their naturalism and safety. Though herbal drugs are proven efficacious and safe, in chronic ailments like diabetes and hypertension the usage of conventional drugs has become inevitable. However, this combinatorial usage of conventional and herbal drugs is resulting into side effects, due to their herb-drug interactions. For this reason, healthcare providers and consumers have a definite need to know the possible side effects from these herbal drugs use in combination with conventional drugs. A large number of in-vivo and in-vitro experiments and clinical studies have cast light on the possible effects of botanical products and phytochemicals on the many enzymes and transporters involved in gastrointestinal drug absorption. Herbal-drug interactions can be characterized as either pharmacodynamic (PD) or pharmacokinetic (PK) in nature. PD interactions may occur when constituents of herbal products have either synergistic or antagonist activity in relation to a conventional drug. PK interactions result from alteration of absorption, distribution, metabolism, or elimination of a conventional drug by an herbal drug or other dietary supplements. There are several reports on herb-drug interactions. In pharmacokinetic interaction of Withania somnifera , Triphala and its individual components with rosiglitazone in diabetic rats decreased the bioavailability may be attributed to decreased absorption of rosiglitazone in the presence of these herbs or induction of CYP2C8 enzyme which metabolizes rosiglitazone. The pharmacodynamic findings also reveal that there is enhancement in the hypoglycemic activity of rosiglitazone. Piperine and curcumin along with glimepiride in normal and diabetic rats increase in bioavailability due to inhibition of CYP enzyme (CYP2C9) responsible for glimepiride metabolism. Rutin pretreatment increased the bioavailability of glibenclamide in normal and diabetic rats. The increase in bioavailability may be due to inhibition of CYP2C9 enzyme, responsible for glibenclamide metabolism. The pharmacodynamic findings also revealed that there is enhancement in the hypoglycemic activity of glibenclamide. Rutin, monoammonium glycyrrhizhinate and gallic acid have significant effect on the rosiglitazone indicating that they may also alter the pharmacokinetics of other drugs metabolized by CYP2C8. In another study, there is a significant herb-drug interaction of Echinacea purpurea , Withania somnifera and Sambucus nigra with zidovudine and also Noni juice and Ginkgo biloba with phenytoin and carbamazepine which might be attributed to inhibition of CYP2C9 and induction of CYP3A4 enzymes. A sound knowledge and a clear understanding of the mechanisms of herb-drug interactions is essential for clinical risk assessment, which in turn provide a vital information to healthcare professionals to minimize risk and ensure the safety of herbal medicinal products.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Biochemistry & Pharmacology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ciddi Veeresham”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels